Article
Use of Fetal Fibronectin in Clinical Practice
1 Apr 1997
Abstract excerpt
Preterm delivery remains a worldwide problem hindered by many unknowns, not the least of which is an inability to detect patients at risk for this complication of pregnancy. A unique form of fibronectin identified in the extracellular matrix surrounding the extravillous trophoblast at the uteroplacental junction contains an epitope called the "oncofetal domain," which is recognized by the monoclonal antibody...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.